Literature DB >> 11544337

IL-3 induces down-regulation of CCR3 protein and mRNA in human eosinophils.

Y Dulkys1, C Kluthe, T Buschermöhle, I Barg, S Knöss, A Kapp, A E Proudfoot, J Elsner.   

Abstract

Cytokines and chemokines are responsible for the attraction and activation of eosinophils in allergic and inflammatory diseases. Whereas cytokines such as IL-3, IL-5, and GM-CSF activate eosinophils via heterodimeric receptors containing a distinct alpha-chain (binding domain) and a common beta-chain (signaling domain), chemokines such as eotaxin activate eosinophils via seven-transmembrane G(i) protein-coupled CCRs. Recent studies have demonstrated the importance of CCR3 on human eosinophils that undergo receptor recycling after chemokine activation, but the modulation of this receptor by cytokines has not yet been addressed. In this study, we demonstrate that IL-3 induces a dose- and time-dependent down-regulation of CCR3 from the surface of human eosinophils comparable to the CCR3-specific ligand eotaxin, whereas IL-5, GM-CSF, IL-4, IL-10, IL-13, IFN-gamma, and TNF-alpha had no effect. Maximal down-regulation of CCR3 in response to IL-3 was reached at 24 h. Reduction of CCR3 surface protein in response to IL-3 could be prevented by an anti-IL-3 mAb and was neither due to the release of CC chemokines nor to nonspecific binding of IL-3 to CCR3. Moreover, down-regulation was prevented by phenylarsine oxide, a nonspecific inhibitor of receptor internalization. After 24 h, IL-3-induced decrease of CCR3 surface expression correlated with diminished mRNA expression, suggesting a transcriptional regulation mechanism. Since wortmannin partially inhibited IL-3- but not eotaxin-induced CCR3 down-regulation, receptor down-modulation seems to underlie different signaling events. Therefore, these data suggest a novel role for the cytokine IL-3 in the activation process of eosinophils and its predominant chemokine receptor CCR3.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544337     DOI: 10.4049/jimmunol.167.6.3443

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Segmental allergen challenge alters multimeric structure and function of surfactant protein D in humans.

Authors:  Elena N Atochina-Vasserman; Carla Winkler; Helen Abramova; Frank Schaumann; Norbert Krug; Andrew J Gow; Michael F Beers; Jens M Hohlfeld
Journal:  Am J Respir Crit Care Med       Date:  2010-12-03       Impact factor: 21.405

Review 2.  Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.

Authors:  Stephane Esnault; Elizabeth A Kelly
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

3.  Epstein-Barr Virus-induced Gene 2 Mediates Allergen-induced Leukocyte Migration into Airways.

Authors:  Zhong-Jian Shen; Jie Hu; Venkatesh P Kashi; Elizabeth A Kelly; Loren C Denlinger; Kevan Lutchman; Jeffrey G McDonald; Nizar N Jarjour; James S Malter
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

4.  The Role of Heparan Sulfate in CCL26-Induced Eosinophil Chemotaxis.

Authors:  Alexandra Pum; Maria Ennemoser; Tanja Gerlza; Andreas J Kungl
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

5.  Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation.

Authors:  Roma Sehmi; Sandra Dorman; Adrian Baatjes; Rick Watson; Ronan Foley; Sun Ying; Douglas S Robinson; A Barry Kay; Paul M O'Byrne; Judah A Denburg
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

6.  IL-4 engagement of the type I IL-4 receptor complex enhances mouse eosinophil migration to eotaxin-1 in vitro.

Authors:  Nicola M Heller; William M Gwinn; Raymond P Donnelly; Stephanie L Constant; Achsah D Keegan
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

7.  Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model.

Authors:  Emily Mills Ko; Joyce H Ma; Fuzheng Guo; Laird Miers; Eunyoung Lee; Peter Bannerman; Travis Burns; David Ko; Jiho Sohn; Athena M Soulika; David Pleasure
Journal:  J Neuroinflammation       Date:  2014-06-12       Impact factor: 8.322

8.  Eosinophil-Mediated Immune Control of Adult Filarial Nematode Infection Can Proceed in the Absence of IL-4 Receptor Signaling.

Authors:  Nicolas Pionnier; Hanna Sjoberg; Julio Furlong-Silva; Amy Marriott; Alice Halliday; John Archer; Andrew Steven; Mark J Taylor; Joseph D Turner
Journal:  J Immunol       Date:  2020-06-22       Impact factor: 5.422

9.  Human eosinophil activin A synthesis and mRNA stabilization are induced by the combination of IL-3 plus TNF.

Authors:  Elizabeth A Kelly; Stephane Esnault; Sean H Johnson; Lin Ying Liu; James S Malter; Mandy E Burnham; Nizar N Jarjour
Journal:  Immunol Cell Biol       Date:  2016-03-22       Impact factor: 5.126

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.